Citation 45082

MUGGIA,FM: CREAVEN,PJ: HANSEN,HH: COHEN,MH: SELAWRY,OS:. (1972). PHASE I CLINICAL TRIAL OF WEEKLY AND DAILY TREATMENT WITH CAMPTOTHECIN (NSC-100880): CORRELATION WITH PRECLINICAL STUDIES.. 56()

Citation Details

Title	PHASE I CLINICAL TRIAL OF WEEKLY AND DAILY TREATMENT WITH CAMPTOTHECIN (NSC-100880): CORRELATION WITH PRECLINICAL STUDIES.
Authors	MUGGIA,FM: CREAVEN,PJ: HANSEN,HH: COHEN,MH: SELAWRY,OS:
Year	1972
Volume	56
Issue

Summary

Year: 1972

Journal: Unknown

Organisms and Their Experiments (1)

Camptotheca acuminata (NYSSACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	EQUIVOCAL
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	ACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAMPTOTHECIN	ACTIVE

Show SPARQL Queries (1)